MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.semarthrit.2023.152208

Медицинская библиотека · Seminars in arthritis and rheumatism · 2023

Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review.

Maltez Nancy, Hughes Michael, Brown Edith, Hickey Virginia, Shea Beverley, Herrick Ariane L, Proudman Susanna, Merkel Peter A, Pauling John D

СтатьяScoping ReviewПеревод в очереди

Аннотация

BACKGROUND

Raynaud's phenomenon (RP) is a cardinal feature of SSc and is associated with significant disease-related morbidity that impacts on quality of life. The assessment of SSc-RP is challenging. The aim of this scoping review was to evaluate the outcome domains studied and outcome measures used in clinical studies of SSc-RP.

METHODS

Embase, MEDLINE, and the Cochrane Central Register of Controlled Trials were used to identify randomized control trials (RCTs), quasi-randomized studies, case-control studies, prospective and retrospective cohort studies, case series, and cross-sectional studies of adult participants with SSc-associated RP, written in English. A minimum of 25 participants for studies of imaging modalities and 40 participants for questionnaire-based studies was required for inclusion. Basic laboratory and genetic studies were excluded. No limitations were imposed based on intervention, comparator, or study setting. Study characteristics and primary and secondary target domains in each study were recorded.

RESULTS

58 studies (24 randomized clinical trials) were included in the final analysis. The commonest domains captured were severity of attacks (n=35), frequency of attacks (n=28), and duration of attacks (n=19). Objective assessments of digital perfusion were also commonly used in studies of SSc-RP.

CONCLUSION

The outcome domains and the associated outcomes used to assess the impact of SSc-RP in research studies are broad and have varied across studies. The results of this study will inform the OMERACT Vascular Disease in Systemic Sclerosis Working Group to establish a core set of disease domains encompassing the impact of RP in SSc.

Для цитирования: Maltez Nancy, Hughes Michael, Brown Edith, Hickey Virginia, Shea Beverley, Herrick Ariane L, Proudman Susanna, Merkel Peter A, Pauling John D. Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review.. Seminars in arthritis and rheumatism. 2023. DOI: 10.1016/j.semarthrit.2023.152208.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.